Peptit-Majör Histokompatibilite Kompleks I Tetramerleri ile Antijen Spesifik CD8+ T Hücrelerinin Hedeflenmesi ve Aktivasyonu


Arş. Gör. Dr. ŞAFAK CEREN USLU ŞIVGIN

Tez Türü: Doktora

Tezin Yürütüldüğü Kurum: Hacettepe Üniversitesi, Sağlık Bilimleri Enstitüsü, Temel Onkoloji A.B.D., Türkiye

Tez Danışmanı: Hande Canpınar

Tezin Onay Tarihi: 2025

Tezin Dili: İngilizce

Desteklendiği Program: Diğer

Özet:

T lymphocytes are key players in immune

defense, recognizing tumor or infected cells through T-cell receptors (TCRs) that bind

peptide–MHC (pMHC) complexes. However, this interaction is often too weak for

effective detection of antigen-specific T cells. To enhance binding avidity, multimeric

pMHC molecules are used, but traditional tetramerization strategies may miss TCRs

recognizing low-stability yet immunogenic peptides. Moreover, in vivo use is limited

by the need to engineer new pMHC constructs for each peptide, posing time and cost

challenges. This thesis introduces a modular strategy using sortase-mediated ligation

and azide–alkyne click chemistry to generate stable pMHC complexes. An azide group

was added to β2-microglobulin near the peptide-binding cleft, and peptides with a

poly-glycine spacer and alkyne group were covalently linked. The resulting complexes

showed high TCR binding and stability for over three months at 4 °C without free

peptide. This system notably stabilized SIINYEKL, a weak MHC binder. Additionally,

costimulatory dimeric pMHC constructs were developed using nanobody technology

and mammalian expression. While structurally successful, these constructs did not

promote expected T cell proliferation. Further optimization is needed. Overall, this

work presents a flexible platform for detecting and activating antigen-specific T cells

with potential in personalized immunotherapy.